Treating depression in the elderly: Remedying an underdiagnosed disorder

Consultant

Volumn 39, Issue 5, 1999, Pages 1565-1579

  Zal, H Michael ^a,b,c  

^a PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^b Philadelphia Coll Osteopathic Med ^*

^c AMERICAN PSYCHIATRIC ASSOCIATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMFEBUTAMONE; AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTINEOPLASTIC AGENT; ANTIPARKINSON AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CENTRAL STIMULANT AGENT; CIMETIDINE; CITALOPRAM; CORTICOSTEROID; CYCLOSERINE; DESIPRAMINE; DOXEPIN; FLUOXETINE; FLUVOXAMINE; HORMONE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; PSYCHOTROPIC AGENT; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE;

AGED; DEPRESSION; DRUG INDUCED DISEASE; DRUG SAFETY; ELECTROCONVULSIVE THERAPY; GERIATRIC CARE; GERIATRIC PATIENT; HIGH RISK POPULATION; HUMAN; INSOMNIA; MEDICINAL PLANT; NAUSEA; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; SEXUAL DYSFUNCTION; SUICIDE; TREATMENT PLANNING;

EID: 0032832020     PISSN: 00107069     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Johnson J, Weissman MM, Klerman GL Service utilization and social morbidity associated with depressive symptoms in the community. JAMA. 1992; 267:1478-1483.
2. Lebowitz BD. Diagnosis and treatment of depression in late life: an overview of the NIH consensus statement. Am J Geriatr Psychiatry. 1996;4(suppl 1): S3-S6.
3. De Leo D, Diekstra RFW. Depression and Suicide in Late Life. Lewiston, NY: Hogrefe & Huber Publishers; 1990:177-197.
4. Schneider LS. Pharmacologic considerations in the treatment of late-life depression. Am Geriatr Psychiatry. 1996;4(suppl 1):S51-S65.
5. Hooper SC, Vaughan KJ, Tennant CC, Perz JM. Major depression and refusal of life-sustaining medical treatment in the elderly. Med J Aust. 1996;165: 416-419.
6. Dunner DL, Cohn JB, Walshe T III, et al. Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression. J Clin Psychiatry. 1992;53(suppl): 57-60.
7. Price JS, Waller PC, Wood SM, MacKay AV. A comparison of the post-marketing safety of four selective serotonin reuptake inhibitors including the investigation of symptoms occurring on withdrawal. Br J Clin Pharmacol. 1996;42:757-763.
8. Robinson DS, Marcus RN, Archibald DG, Hardy SA. Therapeutic dose range of nefazodone in the treatment of major depression. J Clin Psychiatry. 1996;57(suppl 2):6-9.
9. Salzman C. Monoamine oxidase inhibitors and atypical anodepressants. Clin Geriatr Med. 1992; 8:335-348.
10. Joffe RT, Schuller DR. An open study of buspirone augmentation of serotonin reuptake inhibitors in refractory depression. J Clin Psychiatry. 1993;54(7):269-271.
11. Zal HM. Depression in the elderly patient In: Taylor RB, ed. Difficult Medical Management. Philadelphia: WB Saunders Co; 1991:187-194.
12. Satel SL, Nelson JC. Stimulants in the treatment of depression: a critical overview. J Clin Psychiatry. 1989;50(7):241-249.
13. Sedlacek MJ, Burke WJ. A review, family practice rectification. Geriatr Psychopharmacol. 1991;13: 2:70-90.
14. Lipp FJ. The efficacy, history and politics of medicinal plants. Alternative Ther. 1996;2(4):36-41.
15. Linde K, Ramirez G, Mulrow CD, et al. St John's wort for depression - an overview and metaanalysis of randomised clinical trials. BMJ. 1996; 313:253-258.
16. Castleman M. The Healing Herbs. Emmaus, Pa: Rodale Press; 1991:321-325.
17. Le Bars PL, Katz MM, Berman N, et al. A placebo-controlled, double-blind, randomized trial of an extract of ginkgo biloba for dementia North American EGb Study Group. JAMA. 1997278: 327-332.
18. Martorano JT, Kildahl JP. Beyond Negative Thinking. New York: Insight Books/Plenum Press; 1989:189-203.
19. Thompson LW. Cognitive-behavioral therapy and treatment for late-life depression. J Clin Psychiatry. 1996;57(suppl 5):29-37.
20. Kroessler D, Fogel B. Electroconvulsive therapy for major depression in the oldest old. Am J Geriatr Psychiatry. 1993;1:30-37.
21. Lavretsky H. Late-life depression: risk factors, treatment, and sex differences. Clin Geriatrics. 1998;6:3:13-24.
22. Fogel BS. The psychiatrist's role in choosing a nursing home. Psychiatric Times. 1998;15(special report):71-73.
23. Nemeroff CB, DeVane CL, Pollock BG. Newer antidepressants and the cytochrome P450 system. Am J Psychiatry. 1996;153:311-320.
24. Riesenman C. Antidepressant drug interactions and the cytochrome P450 system: a critical appraisal. Pharmacotherapy. 1995;15(6 pt 2):84S-99S.
25. Richelson E. Pharmacology of antidepressants - characteristics of the ideal drug. Mayo Clin Proc. 1994;69:1069-1081.
26. Nemeroff CB. Drug interactions in perspective: presented at the American Society of Clinical Psychopharmacology, Inc, round table on Antidepressant Treatment The State of the Art, Boston, July 29, 1995. Progress Notes. Fall-Winter 1995-1996;6:(4): 35-37.